Detection of Chlamydia trachomatis and Neisseria gonorrhoeae based on cross-priming amplification

被引:9
|
作者
Yu, B. [1 ]
An, Y. [2 ]
Xu, G. [3 ]
Shan, H. [4 ]
机构
[1] Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Dept Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China
[2] Yulin City First Hosp, Dept Gastroenterol, Xian, Shaanxi, Peoples R China
[3] Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow, Lanark, Scotland
[4] Adicon Clin Labs, 398 Tianmushan Rd, Hangzhou, Zhejiang, Peoples R China
关键词
cross-priming amplification; cross-contamination proof device; disposable amplicon detection; polymerase chain reaction; resource-limited area; sexually transmitted disease; RESOURCE-LIMITED SETTINGS; INFECTIONS; TESTS; PCR;
D O I
10.1111/lam.12560
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Rapid, sensitive and specific isothermal nucleic acid amplification methods of Chlamydia trachomatis (C.trachomatis) and Neisseria gonorrhoeae (N.gonorrhoeae) have been developed based on cross-priming amplification (CPA). The amplicon of CPA can be detected by a disposable amplicon cross-contamination proof device. The whole assay takes 1-15h from amplification to read out. Ten fold serial dilutions of quantified plasmids were used to test the CPA assay sensitivities, with the detection limits of 45 copies per reaction and 65 copies per reaction for C.trachomatis and N.gonorrhoeae respectively. The specificities of CPA assays for C.trachomatis and N.gonorrhoeae were tested by using total DNA extracted from nine other bacterial strains, and no cross-reactivity was detected. Eighty clinical cervical or vaginal swab specimens were tested by both CPA and real-time polymerase chain reaction (PCR) with the consistencies of 9875% (79/80) and 975% (78/80) for C.trachomatis and N.gonorrhoeae respectively. Using real-time PCR as a reference standard, the clinical sensitivity (positive) and specificity (negative) of CPA was found to be 9815% (53/54) and 100% (26/26) for C.trachomatis, and 9375% (30/32) and 100% (48/48) for N.gonorrhoeae. Eight swab specimens tested positive for both C.trachomatis and N.gonorrhoeae simultaneously by real-time PCR and CPA assay. This study demonstrated that CPA is an affordable and accessible assay for C.trachomatis and N.gonorrhoeae detection, with high sensitivity and specificity. Significance and Impact of the StudyRapid and specific detection of the sexually transmitted pathogens Chlamydia trachomatis (C.trachomatis) and Neisseria gonorrhoeae (N.gonorrhoeae) would enable early treatment and management of their spread. Here, for the first time, a user friendly DNA isothermal amplification method named cross-priming amplification (CPA), was used to test C.trachomatis and N.gonorrhoeae with high sensitivity and specificity. The results indicate that CPA has great potential for improving C.trachomatis and N.gonorrhoeae diagnostics which could be particularly advantageous in resource-limited areas.
引用
收藏
页码:399 / 403
页数:5
相关论文
共 50 条
  • [41] A multiplex PCR assay for the simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis
    Abou Tayoun, Ahmad N.
    Burchard, Paul R.
    Caliendo, Angela M.
    Scherer, Axel
    Tsongalis, Gregory J.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2015, 98 (02) : 214 - 218
  • [42] Evaluation of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Boyadzhyan, B
    Yashina, T
    Yatabe, JAH
    Patnaik, M
    CLINICAL CHEMISTRY, 2001, 47 (11) : 2082 - 2082
  • [43] Detection of TMA amplified Chlamydia trachomatis and Neisseria gonorrhoeae rRNA in the VIDAS instrument.
    Lauzier, WD
    Morin, M
    Moe, J
    Catanzariti, L
    Burres, E
    Levasseur, PJ
    CLINICAL CHEMISTRY, 1998, 44 : A31 - A32
  • [44] MULTIPLEX PCR FOR DETECTION OF CHLAMYDIA-TRACHOMATIS AND NEISSERIA-GONORRHOEAE IN GENITOURINARY SPECIMENS
    MAHONY, JB
    LUINSTRA, KE
    TYNDALL, M
    SELLORS, JW
    KREPEL, J
    CHERNESKY, M
    JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (11) : 3049 - 3053
  • [45] Extragenital Screening Is Essential for Comprehensive Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in the Pediatric Population
    Uprety, Priyanka
    Maria Cardenas, Ana
    JOURNAL OF CLINICAL MICROBIOLOGY, 2019, 57 (06)
  • [46] Point-of-Care Testing for Chlamydia trachomatis and Neisseria gonorrhoeae
    LeBar, William
    POINT OF CARE, 2009, 8 (04): : 164 - 165
  • [47] Purulent keratoconjunctivitis due to Neisseria gonorrhoeae and Chlamydia trachomatis coinfection
    Arvai, Mariann
    Ostorhazi, Eszter
    Mihalik, Noemi
    Karapti, Sarolta
    Marschalko, Marta
    ORVOSI HETILAP, 2013, 154 (21) : 834 - 837
  • [48] Screening of Chlamydia Trachomatis and Neisseria Gonorrhoeae with PCR During Pregnancy
    Taskin, Mine Islimye
    Alpay, Yesim
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2015, 6 : 599 - 602
  • [49] Multicenter Study of Nucleic Acid Amplification Tests for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Children Being Evaluated for Sexual Abuse
    Black, Carolyn M.
    Driebe, Elizabeth M.
    Howard, Laurie A.
    Fajman, Nancy N.
    Sawyer, Mary K.
    Girardet, Rebecca G.
    Sautter, Robert L.
    Greenwald, Earl
    Beck-Sague, Consuelo M.
    Unger, Elizabeth R.
    Igietseme, Joseph U.
    Hammerschlag, Margaret R.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (07) : 608 - 613
  • [50] Diagnostic relevance of simultaneous testing for Chlamydia trachomatis and Neisseria gonorrhoeae
    B. Sakem
    R. Michel
    U. E. Nydegger
    D. Radjenovic
    M. Wydler
    M. Risch
    L. Risch
    Infection, 2011, 39 : 231 - 237